Literature DB >> 17015466

Phosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entry.

Amit Kumar1, Miriam Marqués, Ana C Carrera.   

Abstract

Phosphoinositide 3-kinase (PI3K) is one of the early-signaling molecules induced by growth factor (GF) receptor stimulation that are necessary for cell growth and cell cycle entry. PI3K activation occurs at two distinct time points during G(1) phase. The first peak is observed immediately following GF addition and the second in late G(1), before S phase entry. This second activity peak is essential for transition from G(1) to S phase; nonetheless, the mechanism by which this peak is induced and regulates S phase entry is poorly understood. Here, we show that activation of Ras and Tyr kinases is required for late-G(1) PI3K activation. Inhibition of late-G(1) PI3K activity results in low c-Myc and cyclin A expression, impaired Cdk2 activity, and reduced loading of MCM2 (minichromosome maintenance protein) onto chromatin. The primary consequence of inhibiting late-G(1) PI3K was c-Myc destabilization, as conditional activation of c-Myc in advanced G(1) as well as expression of a stable c-Myc mutant rescued all of these defects, restoring S phase entry. These results show that Tyr kinases and Ras cooperate to induce the second PI3K activity peak in G(1), which mediates initiation of DNA synthesis by inducing c-Myc stabilization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015466      PMCID: PMC1636842          DOI: 10.1128/MCB.00783-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Phosphoinositide 3-kinase activation regulates cell division time by coordinated control of cell mass and cell cycle progression rate.

Authors:  Beatriz Alvarez; Elia Garrido; Jose A Garcia-Sanz; Ana C Carrera
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

2.  The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras.

Authors:  Concepcion Jimenez; Carmen Hernandez; Belen Pimentel; Ana C Carrera
Journal:  J Biol Chem       Date:  2002-08-23       Impact factor: 5.157

Review 3.  The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle.

Authors:  W Jonathan Ryves; Adrian J Harwood
Journal:  Prog Cell Cycle Res       Date:  2003

4.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

5.  Cyclin E ablation in the mouse.

Authors:  Yan Geng; Qunyan Yu; Ewa Sicinska; Manjusri Das; Jürgen E Schneider; Shoumo Bhattacharya; William M Rideout; Roderick T Bronson; Humphrey Gardner; Piotr Sicinski
Journal:  Cell       Date:  2003-08-22       Impact factor: 41.582

Review 6.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor.

Authors:  F M Uckun; R K Narla; T Zeren; Y Yanishevski; D E Myers; B Waurzyniak; O Ek; E Schneider; Y Messinger; L M Chelstrom; R Gunther; W Evans
Journal:  Clin Cancer Res       Date:  1998-05       Impact factor: 12.531

8.  Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation.

Authors:  A Klippel; M A Escobedo; M S Wachowicz; G Apell; T W Brown; M A Giedlin; W M Kavanaugh; L T Williams
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

9.  Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead.

Authors:  Lorena Martínez-Gac; Miriam Marqués; Zaira García; Miguel R Campanero; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point.

Authors:  Christoph Schorl; John M Sedivy
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

View more
  27 in total

Review 1.  Network calisthenics: control of E2F dynamics in cell cycle entry.

Authors:  Jeffrey V Wong; Peng Dong; Joseph R Nevins; Bernard Mathey-Prevot; Lingchong You
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

2.  Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.

Authors:  Kota V Ramana; Ravinder Tammali; Satish K Srivastava
Journal:  Mol Cancer Ther       Date:  2010-03-30       Impact factor: 6.261

3.  An animal model of MYC-driven medulloblastoma.

Authors:  Yanxin Pei; Colin E Moore; Jun Wang; Alok K Tewari; Alexey Eroshkin; Yoon-Jae Cho; Hendrik Witt; Andrey Korshunov; Tracy-Ann Read; Julia L Sun; Earlene M Schmitt; C Ryan Miller; Anne F Buckley; Roger E McLendon; Thomas F Westbrook; Paul A Northcott; Michael D Taylor; Stefan M Pfister; Phillip G Febbo; Robert J Wechsler-Reya
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

4.  Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.

Authors:  Sandrine Sander; Dinis P Calado; Lakshmi Srinivasan; Karl Köchert; Baochun Zhang; Maciej Rosolowski; Scott J Rodig; Karlheinz Holzmann; Stephan Stilgenbauer; Reiner Siebert; Lars Bullinger; Klaus Rajewsky
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

5.  APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway.

Authors:  Guihua Wang; Feng Wang; Weifeng Ding; Jingchun Wang; Rongrong Jing; Haiquan Li; Xudong Wang; Yueguo Wang; Shaoqing Ju; Huimin Wang
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

6.  Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells.

Authors:  Li-Juan Fu; Jin-Xia Li; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2008-10-25       Impact factor: 3.358

7.  Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase.

Authors:  Miriam Marqués; Amit Kumar; Isabel Cortés; Ana Gonzalez-García; Carmen Hernández; M Carmen Moreno-Ortiz; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

8.  miR-638 Inhibits immature Sertoli cell growth by indirectly inactivating PI3K/AKT pathway via SPAG1 gene.

Authors:  Pandi Hu; Kaifeng Guan; Yue Feng; Changping Ma; Huibin Song; Yang Li; Xuanyan Xia; Jialian Li; Fenge Li
Journal:  Cell Cycle       Date:  2017-11-09       Impact factor: 4.534

9.  Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4.

Authors:  Wen-Bin Tsai; Isamu Aiba; Soo-yong Lee; Lynn Feun; Niramol Savaraj; Macus Tien Kuo
Journal:  Mol Cancer Ther       Date:  2009-12       Impact factor: 6.261

Review 10.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.